BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kerman DH, Deshpande AR. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management. Postgrad Med. 2014;126:7-19. [PMID: 25141239 DOI: 10.3810/pgm.2014.07.2779] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Machado APDF, Geraldi MV, do Nascimento RP, Moya AMTM, Vezza T, Diez-Echave P, Gálvez JJ, Cazarin CBB, Maróstica Júnior MR. Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments. Food Res Int 2021;140:110018. [PMID: 33648249 DOI: 10.1016/j.foodres.2020.110018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
2 Ryma T, Samer A, Soufli I, Rafa H, Touil-boukoffa C. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs). Gastroenterology Insights 2021;12:56-66. [DOI: 10.3390/gastroent12010006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Xin Z, Zhai Z, Long H, Zhang F, Ni X, Deng J, Yi L, Deng B. Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease. Mediators Inflamm 2020;2020:6020247. [PMID: 33029104 DOI: 10.1155/2020/6020247] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Chervy M, Barnich N, Denizot J. Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn's Disease. Int J Mol Sci 2020;21:E3734. [PMID: 32466328 DOI: 10.3390/ijms21103734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
5 Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr 2019;7:432. [PMID: 31709203 DOI: 10.3389/fped.2019.00432] [Cited by in Crossref: 27] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
6 Ganguly S, Sabikhi L, Singh AK. Effect of whey-pearl millet-barley based probiotic beverage on Shigella-induced pathogenicity in murine model. Journal of Functional Foods 2019;54:498-505. [DOI: 10.1016/j.jff.2019.01.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Jang H, Lee H, Jang S, Han MJ, Kim D. Evidence for interplay among antibacterial-induced gut microbiota disturbance, neuro-inflammation, and anxiety in mice. Mucosal Immunol 2018;11:1386-97. [DOI: 10.1038/s41385-018-0042-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 71] [Article Influence: 14.0] [Reference Citation Analysis]
8 Kaur K, Saxena A, Debnath I, O'Brien JL, Ajami NJ, Auchtung TA, Petrosino JF, Sougiannis AJ, Depaep S, Chumanevich A, Gummadidala PM, Omebeyinje MH, Banerjee S, Chatzistamou I, Chakraborty P, Fayad R, Berger FG, Carson JA, Chanda A. Antibiotic-mediated bacteriome depletion in ApcMin/+ mice is associated with reduction in mucus-producing goblet cells and increased colorectal cancer progression. Cancer Med. 2018;7:2003-2012. [PMID: 29624892 DOI: 10.1002/cam4.1460] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
9 Hou Q, Ye L, Liu H, Huang L, Yang Q, Turner JR, Yu Q. Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22. Cell Death Differ 2018;25:1657-70. [PMID: 29459771 DOI: 10.1038/s41418-018-0070-2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 123] [Article Influence: 21.8] [Reference Citation Analysis]
10 Sivignon A, Bouckaert J, Bernard J, Gouin SG, Barnich N. The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease. Expert Opinion on Therapeutic Targets 2017;21:837-47. [DOI: 10.1080/14728222.2017.1363184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
11 Hou Q, Ye L, Huang L, Yu Q. The Research Progress on Intestinal Stem Cells and Its Relationship with Intestinal Microbiota. Front Immunol 2017;8:599. [PMID: 28588586 DOI: 10.3389/fimmu.2017.00599] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
12 Vineis JH, Ringus DL, Morrison HG, Delmont TO, Dalal S, Raffals LH, Antonopoulos DA, Rubin DT, Eren AM, Chang EB, Sogin ML. Patient-Specific Bacteroides Genome Variants in Pouchitis. mBio 2016;7:e01713-16. [PMID: 27935837 DOI: 10.1128/mBio.01713-16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
13 Bai J, jie H, wei S, Wang S, Guo H, Tang Q. GART mediates the renewal of intestinal epithelial barrier via p38/p53/PUMA cascade in colitis. Apoptosis 2016;21:1386-97. [DOI: 10.1007/s10495-016-1301-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lu K, Mahbub R, Fox JG. Xenobiotics: Interaction with the Intestinal Microflora. ILAR J 2015;56:218-27. [PMID: 26323631 DOI: 10.1093/ilar/ilv018] [Cited by in Crossref: 57] [Cited by in F6Publishing: 63] [Article Influence: 9.5] [Reference Citation Analysis]
15 Van de Wiele T, Van Praet JT, Marzorati M, Drennan MB, Elewaut D. How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol. 2016;12:398-411. [PMID: 27305853 DOI: 10.1038/nrrheum.2016.85] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 11.8] [Reference Citation Analysis]
16 Matijašić M, Meštrović T, Perić M, Čipčić Paljetak H, Panek M, Vranešić Bender D, Ljubas Kelečić D, Krznarić Ž, Verbanac D. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci 2016;17:E578. [PMID: 27104515 DOI: 10.3390/ijms17040578] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
17 Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1078-1087 [PMID: 26811648 DOI: 10.3748/wjg.v22.i3.1078] [Cited by in CrossRef: 128] [Cited by in F6Publishing: 107] [Article Influence: 21.3] [Reference Citation Analysis]
18 Abdel Hadi L, Di Vito C, Riboni L. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm 2016;2016:3827684. [PMID: 26880864 DOI: 10.1155/2016/3827684] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
19 Qiu X, Li X, Wu Z, Zhang F, Wang N, Wu N, Yang X, Liu Y. Fungal–bacterial interactions in mice with dextran sulfate sodium (DSS)-induced acute and chronic colitis. RSC Adv 2016;6:65995-6006. [DOI: 10.1039/c6ra03869g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Kell D, Potgieter M, Pretorius E. Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res 2015;4:179. [PMID: 26629334 DOI: 10.12688/f1000research.6709.2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
21 Kell D, Potgieter M, Pretorius E. Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res 2015;4:179. [PMID: 26629334 DOI: 10.12688/f1000research.6709.2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]